Takeda named in suits over use of Actos

Actos lawyerThree couples have filed lawsuits that claim Takeda Pharmaceutical Company Limited, the manufacturer of Actos, hid the fact that the drug has been associated with a risk of cancer.

The three men involved in the suit claim to have taken Actos daily as a part of their type-2 diabetes treatment given to them by their doctor. It took several years for the men learned of the association between the blood-sugar lowering medication and increased risk of developing bladder cancer.

According to the complaint, all three men involved in the lawsuit have been diagnosed with bladder cancer since taking Actos.

More

Share

FDA Warns About Cipro, Other Antibiotics

Drug safety officials on July 8, 2008, imposed the government’s most urgent warning on Cipro and similar antibiotics. Officials cited evidence that they may lead to tendon ruptures, a serious injury which can leave patients incapacitated and needing extensive surgery.

The FDA ordered makers of flouroquinolone drugs — a potent class of antibacterials — to add a very visible “black box” warning to their products and write new literature warning patients.

The two leading drugs covered by the warning are Bayer’s Cipro and Ortho-McNeil’s Levaquin. Cipro became a household name during the hysteria after the anthrax attacks of 2001. Cipro is thought to be effective against that bacteria, and it’s among the medications stockpiled by the government. In everyday medicine, Cipro is often used to treat urinary tract infections. Levaquin is generally used to treat respiratory infections.

More

Share